The latest emerging drugs for the treatment of diabetic cardiomyopathy
Expert Opin Pharmacother. 2024 Apr 25. doi: 10.1080/14656566.2024.2347468. Online ahead of print.ABSTRACTINTRODUCTION: Diabetic cardiomyopathy (DCM) is a serious complication of diabetes mellitus involving multiple pathophysiologic mechanisms. In addition to hypoglycemic agents commonly used in diabetes, metabolism-related drugs, natural plant extracts, melatonin, exosomes, and rennin-angiotensin-aldosterone system are cardioprotective in DCM. However, there is a lack of systematic summarization of drugs for DCM.AREAS COVERED: In this review, the authors systematically summarize the most recent drugs used for the treatment of DCM and discusses them from the perspective of DCM pathophysiological mechanisms.EXPERT OPINION: We discuss DCM drugs from the perspective of the pathophysiological mechanisms of DCM, mainly including inflammation and metabolism. As a disease with multiple pathophysiological mechanisms, the combination of drugs may be more advantageous, and we have discussed some of the current studies on the combination of drugs.PMID:38660817 | DOI:10.1080/14656566.2024.2347468
Source: Expert Opinion on Pharmacotherapy - Category: Drugs & Pharmacology Authors: Minghao Li Lin Liu Chunyu Zhang Li Deng Yi Zhong Bin Liao Xiuying Li Ying Wan Jian Feng Source Type: research
More News: Cardiology | Cardiomyopathy | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Endocrinology | Heart | Melatonin | Study